NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc. announced today that the Company has filed a registration statement with the U.S. Securities and Exchange Commission relating to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results